Quarterly Result5 Feb 2026, 04:19 pm
Citurgia Biochemicals Ltd to Approve Q3 FY2025-26 Financial Results on Feb 14, 2026
AI Summary
Citurgia Biochemicals Ltd has announced that its Board of Directors will meet on February 14, 2026, to consider and approve the unaudited standalone financial results for the quarter ended December 31, 2025. The trading window for the company's directors, officers, designated employees, and other connected persons will close on January 1, 2026, and will open 48 hours after the financial results are declared to the stock exchanges.
Key Highlights
- Citurgia Biochemicals Ltd to approve Q3 FY2025-26 financial results on Feb 14, 2026
- The meeting will consider and approve unaudited standalone financial results for the quarter ended Dec 31, 2025
- Trading window for company's directors, officers, designated employees, and other connected persons to close on Jan 1, 2026
- Trading window to open 48 hours after the financial results are declared to stock exchanges
Price Impact
More from CITURGIA